Linklaters has advised funds managed by Apax Partners on the deal. Apax Partners sold shares in Neuraxpharm, a leading European pharmaceutical company focusing on the treatment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
